Los Angeles Times

J&J;’s Procrit Anemia Drug Found to Be Diluted

Johnson & Johnson said some of its Procrit anemia treatment was found diluted to greatly reduce the amount of active medicine in the solution, the latest in a string of drug counterfeiting incidents ...
Business Insider

FDA approves first epoetin alfa biosimilar for the treatment of anemia

SILVER SPRING, Md., May 15, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the ...
Los Angeles Times

Amgen Cites Study on Its Anemia Drug

When it comes to defending its anemia drug business, Amgen Inc. of Thousand Oaks is betting that less is more. Over the weekend, the biotech giant released data from a large clinical trial suggesting ...
The Washington Post

Anemia Drug May Harm Some Patients, FDA Says

The Food and Drug Administration warned yesterday that anemia-fighting drugs called erythropoietins, which had $10 billion in U.S. sales last year, are being used so aggressively that they may be ...